Ignite Creation Date:
2024-05-06 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 2:20 PM
Study NCT ID:
NCT05165225
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-15
First Post:
2021-12-20
Brief Title:
Phase II Neoadjuvant Pyrotinib Combined With Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer a Single-arm Non-randomized Single-center Open Label Trial
Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neoadjuvant Therapy |
| Breast Cancer |
| HER2-low-expressing Breast Cancer |
| Hormone Receptor-positive Breast Cancer |
Keywords: